AZO
46
-3
XEL
67
2
KMX
58
3
GRMN
62
-3
CAH
47
3
IPG
49
10
TGNA
53
2
ILMN
32
-3
ZTS
47
2
AA
51
3
CMCSA
48
2
JWN
40
-2
FOXA
55
9
F
43
-8
C
58
-2
BA
52
2
HSY
34
3
SCHW
64
2
TDC
75
4
PBI
60
-5
AZO
46
-3
XEL
67
2
KMX
58
3
GRMN
62
-3
CAH
47
3
IPG
49
10
TGNA
53
2
ILMN
32
-3
ZTS
47
2
AA
51
3
CMCSA
48
2
JWN
40
-2
FOXA
55
9
F
43
-8
C
58
-2
BA
52
2
HSY
34
3
SCHW
64
2
TDC
75
4
PBI
60
-5
Financhill
Back

AbbVie Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
31

ABBV
AbbVie

Last Price:
169.27
Seasonality Move:
6.01%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

AbbVie Stock Forecast

  • Over the next 52 weeks, AbbVie has on average historically risen by 13.5% based on the past 11 years of stock performance.
  • AbbVie has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is AbbVie Stock Undervalued?
    The current AbbVie [ABBV] share price is $167.76. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will AbbVie Stock Go Up Next Year?

  • Over the next 52 weeks, AbbVie has on average historically risen by 13.5% based on the past 11 years of stock performance.

AbbVie Stock Rating

Sell
31
AbbVie (ABBV) is a Sell

Is AbbVie overpriced?

  • AbbVie has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

AbbVie Stock Price History

Is ABBV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
abbvieinvestor.com

52-Week Data

52-Week High:
207.32
52-Week Low:
137.65

Prediction Charts

Market Cap:
296.46B
Price in USD:
167.76
Volume:
6.24M
Beta:
0.81

Technical Analysis

SMA50:
190.37
SMA100:
187.48
SMA200:
178.80
52-Wk Change:
21.29%

Stock Predictions

  • Is AbbVie stock public?
    Yes, AbbVie is a publicly traded company.
  • What is the AbbVie stock quote today?
    The AbbVie stock price is 167.76 USD today.
  • How to buy AbbVie stock online?
    You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 204.37 203.55 204.73 202.32
Nov-4 203.79 200.47 204.24 200.22
Nov-5 200.49 201.68 202.42 198.35
Nov-6 205.79 201.20 206.15 200.85
Nov-7 201.95 200.51 202.32 199.22
Nov-8 201.16 199.50 201.89 199.48
Nov-11 178.22 174.43 178.57 172.70
Nov-12 176.01 171.09 176.63 171.03
Nov-13 170.97 170.35 172.64 169.65
Nov-14 170.00 169.63 171.62 168.59
Nov-15 169.63 164.99 169.63 164.72
Nov-18 164.99 166.28 166.74 164.80
Nov-19 165.27 166.57 167.10 163.81
Nov-20 166.91 167.76 167.91 165.65

AbbVie Earnings

AbbVie Earnings Report: Per Share AbbVie Earnings Q1 Q2 Q3 and Q4 last year and next year.

AbbVie Forecast Revenue Growth

AbbVie Stock Analysis: Historical quarterly revenues per share for AbbVie and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.